Ceres Nanosciences

OverviewSuggest Edit

Ceres Nanosciences Inc. (“Ceres”) is engaged in the research, development, and commercialization of innovative sample preparation products and diagnostic tests, based on its proprietary Nanotrap particle platform. The Nanotrap captures, enriches and preserves the most valuable biomarkers, enabling early and accurate detection of diseases such as cancer, cardiac, and infectious diseases, resulting in improved patient outcomes and reduced health care costs.

Ceres has a broad product pipeline of advanced sample collection technologies and diagnostic tests powered by its Nanotrap technology. Ceres’ lead product is a direct antigen test for the diagnosis of Lyme disease, which is now available commercially as a Laboratory Developed Test and is under development for point of care delivery.

Ceres is working with a number of strategic industry partners to integrate the Nanotrap platform into their leading clinical diagnostic tests and R&D workflows. The versatility and performance of the Nanotrap allows Ceres to partner across the life sciences, pharma, and clinical diagnostics space.

HQManassas, US


Ceres Nanosciences is headquartered in
Manassas, United States

Location Map

Latest Updates

Employees (est.) (Sept 2020)28(-6%)
Cybersecurity ratingAMore

Ceres Nanosciences Office Locations

Ceres Nanosciences has an office in Manassas
Manassas, US (HQ)
9385 Discovery Blvd
Show all (1)

Ceres Nanosciences Financials and Metrics

Summary Metrics

Founding Date


Ceres Nanosciences total Funding

$3 m

Ceres Nanosciences latest funding size

$3 m

Time since last funding

4 years ago

Ceres Nanosciences investors

Ceres Nanosciences's latest funding round in February 2017 was reported to be $3 m. In total, Ceres Nanosciences has raised $3 m
Show all financial metrics

Ceres Nanosciences Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Ceres Nanosciences Online and Social Media Presence

Embed Graph

Ceres Nanosciences Frequently Asked Questions

  • When was Ceres Nanosciences founded?

    Ceres Nanosciences was founded in 2008.

  • How many employees does Ceres Nanosciences have?

    Ceres Nanosciences has 28 employees.

  • Who are Ceres Nanosciences competitors?

    Competitors of Ceres Nanosciences include Thriva, Oxford Immunotec and T2 Biosystems.

  • Where is Ceres Nanosciences headquarters?

    Ceres Nanosciences headquarters is located at 9385 Discovery Blvd, Manassas.

  • Where are Ceres Nanosciences offices?

    Ceres Nanosciences has an office in Manassas.

  • How many offices does Ceres Nanosciences have?

    Ceres Nanosciences has 1 office.